Incannex Healthcare is gearing up to move forward with IHL-42X development while advancing PSX-001 into the next clinical phase next year. The biotech project continues to make solid progress on its pipeline, with 2026 shaping up as a key milestone year for these therapeutic programs. Investors tracking healthcare-focused crypto plays should keep tabs on these clinical updates.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • 4
  • Repost
  • Share
Comment
0/400
zkProofGremlinvip
· 6h ago
Biotech and crypto combined? The real results will be seen in 2026. Let's wait and see.
View OriginalReply0
GasDevourervip
· 6h ago
Will 2026 really have such a big impact? I remain skeptical...
View OriginalReply0
Blockwatcher9000vip
· 6h ago
Wait a minute, is this a real breakthrough in biotechnology or just another hype scheme? 2026 is the critical period; it's a bit early to be discussing this now...
View OriginalReply0
GasWastervip
· 6h ago
ngl this biotech thing screams "watch and wait" but 2026 feels so far... meanwhile i'm over here calculating if the gas to bridge into this play even makes sense. failed tx twice already just researching the token lol. why's it always gotta cost so much to be early?
Reply0
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)